131 related articles for article (PubMed ID: 875219)
1. Experimental models for the study of prostatic adenocarcinoma.
Smolev JK; Coffey DS; Scott WW
J Urol; 1977 Jul; 118(1 Pt 2):216-20. PubMed ID: 875219
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the Dunning R3327H prostatic adenocarcinoma: an appropriate animal model for prostatic cancer.
Smolev JK; Heston WD; Scott WW; Coffey DS
Cancer Treat Rep; 1977; 61(2):273-87. PubMed ID: 872132
[TBL] [Abstract][Full Text] [Related]
3. Hormonally responsive versus unresponsive progression of prostatic cancer to antiandrogen therapy as studied with the Dunning R-3327-AT and -G rat adenocarcinomas.
Isaacs JT
Cancer Res; 1982 Dec; 42(12):5010-4. PubMed ID: 6215981
[TBL] [Abstract][Full Text] [Related]
4. Endocrine manipulation of the Dunning prostatic adenocarcinoma.
Shessel FS; Block NL; Stover B; Claflin A; Malinin TI; Politano VA
Invest Urol; 1980 May; 17(6):529-33. PubMed ID: 7372443
[TBL] [Abstract][Full Text] [Related]
5. Cell kinetic studies of prostatic cancer: adjuvant therapy in animal models.
Weissman RM; Coffey DS; Scott WW
Oncology; 1977; 34(3):133-7. PubMed ID: 917443
[TBL] [Abstract][Full Text] [Related]
6. The effects of castration, testosterone and oestrogen on epithelial and stromal growth and morphology of the Dunning (R3327H) prostatic adenocarcinoma.
Damber JE; Landström M; Bergh A; Tomic R
Scand J Urol Nephrol Suppl; 1988; 110():145-8. PubMed ID: 3187402
[No Abstract] [Full Text] [Related]
7. Effectiveness of complete versus partial androgen withdrawal therapy for the treatment of prostatic cancer as studied in the Dunning R-3327 system of rat prostatic adenocarcinomas.
Ellis WJ; Isaacs JT
Cancer Res; 1985 Dec; 45(12 Pt 1):6041-50. PubMed ID: 4063963
[TBL] [Abstract][Full Text] [Related]
8. Animal models of the hormone-sensitive and -insensitive prostatic adenocarcinomas, Dunning R-3327-H, R-3327-HI, and R-3327-AT.
Isaacs JT; Heston WD; Weissman RM; Coffey DS
Cancer Res; 1978 Nov; 38(11 Pt 2):4353-9. PubMed ID: 698976
[TBL] [Abstract][Full Text] [Related]
9. Concepts in prostatic cancer biology: Dunning R-3327 H, HI, and AT tumors.
Isaacs JT; Weissman RM; Coffey DS; Scott WW
Prog Clin Biol Res; 1980; 37():311-23. PubMed ID: 7384091
[TBL] [Abstract][Full Text] [Related]
10. In vivo selection of androgen-insensitive cells in R3327-G rat prostate tumors: diethylstilbestrol diphosphate treatment versus orchiectomy.
Pollack A; Block NL; Stover BJ; Irvin GL; Fuentes MP; Claflin AJ; Malinin TI
J Natl Cancer Inst; 1983 May; 70(5):907-14. PubMed ID: 6573535
[TBL] [Abstract][Full Text] [Related]
11. The effect of castration on tumor growth rate and cell kinetics in hormone sensitive and hormone insensitive rat prostatic adenocarcinomas.
Salling LN; Høyer M; Overgaard J
Scand J Urol Nephrol Suppl; 1995; 172():73-9. PubMed ID: 8578260
[TBL] [Abstract][Full Text] [Related]
12. Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma.
Isaacs JT; Coffey DS
Cancer Res; 1981 Dec; 41(12 Pt 1):5070-5. PubMed ID: 7307008
[TBL] [Abstract][Full Text] [Related]
13. The characterization of a newly identified, highly metastatic variety of Dunning R 3327 rat prostatic adenocarcinoma system: the MAT LyLu tumor.
Isaacs JT; Yu GW; Coffey DS
Invest Urol; 1981 Jul; 19(1):20-3. PubMed ID: 7251319
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric analysis of the response of the R3327-G rat prostatic adenocarcinoma to endocrine manipulation.
Pollack A; Bagwell CB; Block NL; Irvin GL; Claflin AJ; Stover BJ
J Surg Oncol; 1981; 18(4):389-98. PubMed ID: 7321568
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of a cloned cell line R3327H-G8-A1 derived from the dunning R3327H rat adenocarcinoma.
Sestili MA; Norris JS; Smith RG
Cancer Res; 1983 May; 43(5):2167-75. PubMed ID: 6299542
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy of the transplantable adenocarcinoma (R-3327) of the Copenhagen rat.
Block NL; Camuzzi F; Denefrio J; Troner M; Claflin A; Stover B; Politano VA
Oncology; 1977; 34(3):110-3. PubMed ID: 917440
[TBL] [Abstract][Full Text] [Related]
17. Dunning adenocarcinoma in tissue culture: isolation of a cloned cell line, R3327H-G8-A1.
Sestili MA; Norris JS; Lipschultz LI; Smith RG
J Urol; 1982 Apr; 127(4):823-5. PubMed ID: 7040704
[TBL] [Abstract][Full Text] [Related]
18. Unusual androgen sensitivity of the androgen-independent Dunning R-3327-G rat prostatic adenocarcinoma: androgen effect on tumor cell loss.
Humphries JE; Isaacs JT
Cancer Res; 1982 Aug; 42(8):3148-56. PubMed ID: 7093958
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of propagable cell lines (HUNC) from the androgen-sensitive Dunning R3327H rat prostatic adenocarcinoma.
Presnell SC; Borchert KM; Glover WJ; Gregory CW; Mohler JL; Smith GJ
Carcinogenesis; 1998 Apr; 19(4):585-90. PubMed ID: 9600341
[TBL] [Abstract][Full Text] [Related]
20. Histology, histochemistry, and acid phosphatase of Noble (Nb) rat prostate adenocarcinomas and treatment of an androgen-dependent Nb rat prostate adenocarcinoma.
Drago JR; Goldman LB; Maurer RE; Eckels DD; Gershwin ME
J Natl Cancer Inst; 1980 Apr; 64(4):931-7. PubMed ID: 6929004
[No Abstract] [Full Text] [Related]
[Next] [New Search]
